August 11, 2023

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hayward Holdings, Inc. (NYSE: HAYW) between March 2, 2022 and July 27, 2022, both dates inclusive (the “Class Period”), of the important October 2, 2023 lead plaintiff deadline. SO WHAT: If […]

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15, 2021 and June 28, 2023, both dates inclusive (the “Class Period”), of the important September 5, 2023 lead plaintiff deadline. SO WHAT: If you […]

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sea Limited (NYSE: SE) between April 23, 2022 and May 15, 2023, both dates inclusive (the “Class Period”), of the important September 19, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eos Energy Enterprises, Inc. (NASDAQ: EOSE, EOSEW) between May 9, 2022 and July 27, 2023, both dates inclusive (the “Class Period”), of the important October 2, 2023 lead plaintiff deadline. SO WHAT: […]

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021 and July 28, 2023, both dates inclusive (the “Class Period”). A class […]